Clinical Trial Update: SNF Platform Study of HR+/ HER2-advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for a SNF platform study in HR-positive, HER2-negative advanced breast cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Breast Neoplasm, Breast Cancer | Phase 2 | Status: RECRUITING